ABOUT ANDELYN BIOSCIENCES

Andelyn Biosciences is a pioneering gene therapy organization born out of Nationwide Children's Hospital, where the first FDA-approved systemic gene therapy was discovered.

With more than 15 years of experience in AAV vector manufacturing, Andelyn is a full-spectrum CDMO. We bring scalability, capacity, efficiency and expert resources to manufacturing matrices, all to advance the development of viral vector-based therapeutics.

As a global provider of gene therapy solutions, Andelyn has been a trusted partner in over 60 US, EU and ROW clinical trials.

Discover more about our capabilities at AndelynBio.com.

Take a look behind the scenes and hear firsthand about the commitment to patients and clients at Andelyn Biosciences in this video.

A Unique Business Model Benefitting Pediatric Research Through Geriatric Research

As an affiliate organization of Nationwide Children’s Hospital, Andelyn Biosciences’ unique business model allows for reinvestment into pioneering gene therapy research conducted at the world-class Abigail Wexner Research Institute to uncover the next generation of cures for rare diseases.

This forward-thinking business model allows us – and you –  to support the future of gene-based research.

Discover more about the Abigail Wexner Research Institute here: https://www.nationwidechildrens.org/research

CONTACT INFORMATION

Andelyn Biosciences

575 Children's Crossroad

Columbus, OH 43215

UNITED STATES

Phone: 614.946.8969

SOLUTIONS

  • Leveraging more than 15 years in the field, Andelyn Biosciences provides custom development and manufacturing of AAV vectors for gene therapy as a full-service concept-to-commercialization cGMP CDMO.

  • The road to the formation of Andelyn Biosciences started more than 15 years ago on the third floor of a research building at Nationwide Children’s Hospital in Columbus, Ohio. At that time, GMP facilities were unheard of at children’s hospitals and gene therapy research was a rarity.

  • Looking for scalability in clinical manufacturing? Andelyn Biosciences' current Good Manufacturing Practices (cGMP) Clinical Manufacturing Facility operates according to FDA cGMP Guidelines and with multinational health agencies around the world.

FEATURED ARTICLES